bioMerieux (OTCMKTS:BMXMF) Short Interest Down 37.8% in September

bioMerieux (OTCMKTS:BMXMF) was the recipient of a large decline in short interest during the month of September. As of September 15th, there was short interest totaling 85,800 shares, a decline of 37.8% from the August 31st total of 137,900 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 858.0 days. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 858.0 days.

bioMerieux Stock Performance

BMXMF opened at $135.01 on Monday. The stock has a 50-day moving average price of $140.96 and a 200-day moving average price of $136.21. The company has a quick ratio of 1.30, a current ratio of 2.27 and a debt-to-equity ratio of 0.08. bioMerieux has a 1 year low of $100.50 and a 1 year high of $152.00.

About bioMerieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.